-
Gamunex-C
Gamunex-C is an intravenous immunoglobulin (IVIG) therapy derived from human plasma containing antibodies essential to immune system function. At Singlepoint Healthcare, our goal is to provide compassionate, individualized care using advanced therapies like Gamunex-C® IV Therapy, helping patients stabilize symptoms, protect nerve and immune function, and improve overall quality of life.
What is Gamunex-C?
Gamunex-C is used to treat a variety of conditions caused by immune deficiencies or autoimmune dysregulation. It works by modulating the immune system to reduce harmful autoimmune activity, strengthen immune response, and protect against infection or nerve damage.
Administered through a controlled IV infusion, Gamunex-C is delivered by trained healthcare professionals in a safe and comfortable clinical setting. It can be used as a long-term therapy or during acute periods of disease activity, depending on the patient’s diagnosis and treatment plan.
Key Details
Important Information
| Category | Details |
|---|---|
| Conditions It Treats | Primary Humoral Immunodeficiency (PI), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) |
| Manufacturer | Grifols |
| Administered by | Infusion |
| Frequency | Varies by diagnosis |
| FDA Approval(s) | Primary Humoral Immunodeficiency (PI): September 12, 2008 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): October 13, 2010 |